Patient Power®
Get Email Alerts!
Health Topics
Advanced Prostate Cancer Health Center
Health Center Home Get the Latest
Search by Keyword:
Search by Health Topic:
View all Health Topics >
Spring Survey Results 2012

Advanced Prostate Cancer Health Center

Get Email Updates on Advanced Prostate Cancer:

Prostate cancer is considered advanced, or metastatic, when the cancer spreads from the prostate gland to other areas of the body, such as the lymph nodes, bones and lungs. Although there is not currently a curative treatment available for advanced prostate cancer, there are therapies that can slow the growth of the cancer and help patients increase their quality of life. Patient Power’s Advanced Prostate Cancer Health Center is your in-depth resource for up-to-date information from world renowned experts who are changing the treatment landscape and working diligently toward a cure.

Featured Program

April 12, 2012

The Latest for Advanced Prostate Cancer: An Advocate’s Perspective

(More Info)

Latest Videos:

Latest Audio Programs:

Managing the Side Effects of Androgen Deprivation Therapy
Androgen deprivation therapy (ADT) is a treatment for advanced prostate cancer that reduces the levels of male hormones in the body, such as testosterone, on which cancer cells thrive. In...
by Patient Power | 05/09/2012
Doctor as Patient: A Leading Urologist’s Experience as a Prostate Cancer Survivor
Dr. Paul Schellhammer, a leading prostate cancer researcher and urologic oncologist, is intimately familiar with prostate cancer. As an expert in the field, Dr. Schellhammer knew that someday, he too...
by Patient Power | 03/16/2012
Addressing Commentary About IMPACT Trial Results
An active immunotherapy called Provenge (sipuleucel-T) was approved in 2010 to treat advanced prostate cancer and its approval was due, in part, to the positive results of the IMPACT trial....
by Patient Power | 03/12/2012
Expanding Treatment Options for Advanced Prostate Cancer
In this interview, Dr. Philip Kantoff, chief of the division of solid tumor oncology at Dana-Farber Cancer Institute, explores approved and promising therapies for metastatic, castrate-resistant prostate cancer. Dr. Kantoff...
by Patient Power | 02/12/2012